Cetera Investment Advisers’s Vaxart VXRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,275
Closed -$6.9K 4680
2025
Q2
$6.9K Hold
15,275
﹤0.01% 4058
2025
Q1
$6.22K Sell
15,275
-1,315
-8% -$843 ﹤0.01% 3950
2024
Q4
$11K Sell
16,590
-10,100
-38% -$7.02K ﹤0.01% 3723
2024
Q3
$22.7K Sell
26,690
-1,750
-6% -$1.34K ﹤0.01% 3647
2024
Q2
$19K Sell
28,440
-1,255
-4% -$1.04K ﹤0.01% 3652
2024
Q1
$38.6K Buy
+29,695
New +$31.1K ﹤0.01% 3590

Other funds holding VXRT

Cetera Investment Advisers's VXRT Position: Q3 2025 in Review

Cetera Investment Advisers sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 15,275 shares — an estimated $6.9K sold.

Cetera Investment Advisers first reported a position in VXRT in Q1 2024 and held it in 6 quarters. The position peaked at $38.6K in Q1 2024. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Cetera Investment Advisers reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Cetera Investment Advisers sold 15,275 Vaxart shares in Q3 2025, an estimated $6.9K.
  • Cetera Investment Advisers first reported a position in Vaxart in Q1 2024 and held it in 6 quarters.
  • Cetera Investment Advisers's Vaxart position peaked at $38.6K in Q1 2024.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Cetera Investment Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.